Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea.

Abstract

Hydroxyurea is a safe and efficacious medication for children with sickle cell disease (SCD). Our objective was to compare health-related quality of life (HRQL) between children taking hydroxyurea and those not taking hydroxyurea. We conducted a retrospective cohort study of children with SCD who had completed the PedsQL 4.0 at Duke University Medical… (More)
DOI: 10.1097/MPH.0b013e3182114c54

Topics

Cite this paper

@article{Thornburg2011DifferencesIH, title={Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea.}, author={Courtney D Thornburg and Agustin Calatroni and Julie Ann Panepinto}, journal={Journal of pediatric hematology/oncology}, year={2011}, volume={33 4}, pages={251-4} }